Surfaxin (lucinactant)
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 70 (Table of Contents)
Published: 6 Apr-2006
DOI: 10.3833/pdr.v2006.i70.527 ISSN: 1756-7874
Section: Deal Trackers
Fulltext:
Abstract
Surfaxin® is a pulmonary surfactant that contains sinapultide (KL4), a synthetic peptide resembling human surfactant protein B, which was originally developed by Prof Charles G Cochrane at The Scripps Research Institute...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018